James C Hubbard1, Yue Zhang2, Yuqing Qiu2, Minkyoung Yoo3, Andrew R Stephens1, Michelle Zeidan1, Nikolas H Kazmers4. 1. Department of Orthopaedics, University of Utah, Salt Lake City, UT. 2. Division of Public Health, University of Utah, Salt Lake City, UT. 3. Department of Economics, University of Utah, Salt Lake City, UT. 4. Department of Orthopaedics, University of Utah, Salt Lake City, UT. Electronic address: nkazmers@gmail.com.
Abstract
PURPOSE: It is unclear what score changes on the abbreviated Disabilities of the Arm, Hand, and Shoulder (QuickDASH), Patient-Reported Outcomes Measurement Information System (PROMIS) upper extremity (UE) computer adaptive test (CAT), and PROMIS physical function (PF) CAT represent a substantial improvement. We calculated the substantial clinical benefit (SCB) for these 3 instruments in a non-shoulder hand and upper extremity population. METHODS: Adult patients treated between March 2015 and September 2019 at a single academic tertiary institution were identified. The QuickDASH, PROMIS UE CAT v2.0, and PROMIS PF CAT v2.0 scores were collected using a tablet computer. Responses to the QuickDASH both at baseline and follow-up 6 ± 4 weeks later, and a response to the anchor question "Compared to your first evaluation at the University Orthopaedic Center, how would you describe your physical function level now?" were required for inclusion. A second anchor question querying treatment-related improvement was also used. The SCB was calculated using an anchor-based approach comparing the mean change difference between groups reporting no change and a maximal change for both anchor questions. RESULTS: Of 1,119 included participants, the mean age was 48 ± 17 years, 53% were women, and half were recovering from surgery. Score changes between baseline and follow-up were significantly different between groups reporting no improvement and maximal improvement on both anchor questions. The SCB values ranged between 16.9 and 22.8 on the QuickDASH, 5.9 and 7.1 on the UE CAT, and 3.5 and 6.7 on the PF CAT. CONCLUSIONS: These score improvements for the QuickDASH, UE CAT, and PF CAT represent a substantial clinical improvement in a non-shoulder hand and upper extremity population. CLINICAL RELEVANCE: These SCB estimates may assist with the interpretation of outcome scores at a population level.
PURPOSE: It is unclear what score changes on the abbreviated Disabilities of the Arm, Hand, and Shoulder (QuickDASH), Patient-Reported Outcomes Measurement Information System (PROMIS) upper extremity (UE) computer adaptive test (CAT), and PROMIS physical function (PF) CAT represent a substantial improvement. We calculated the substantial clinical benefit (SCB) for these 3 instruments in a non-shoulder hand and upper extremity population. METHODS: Adult patients treated between March 2015 and September 2019 at a single academic tertiary institution were identified. The QuickDASH, PROMIS UE CAT v2.0, and PROMIS PF CAT v2.0 scores were collected using a tablet computer. Responses to the QuickDASH both at baseline and follow-up 6 ± 4 weeks later, and a response to the anchor question "Compared to your first evaluation at the University Orthopaedic Center, how would you describe your physical function level now?" were required for inclusion. A second anchor question querying treatment-related improvement was also used. The SCB was calculated using an anchor-based approach comparing the mean change difference between groups reporting no change and a maximal change for both anchor questions. RESULTS: Of 1,119 included participants, the mean age was 48 ± 17 years, 53% were women, and half were recovering from surgery. Score changes between baseline and follow-up were significantly different between groups reporting no improvement and maximal improvement on both anchor questions. The SCB values ranged between 16.9 and 22.8 on the QuickDASH, 5.9 and 7.1 on the UE CAT, and 3.5 and 6.7 on the PF CAT. CONCLUSIONS: These score improvements for the QuickDASH, UE CAT, and PF CAT represent a substantial clinical improvement in a non-shoulder hand and upper extremity population. CLINICAL RELEVANCE: These SCB estimates may assist with the interpretation of outcome scores at a population level.
Authors: Brinkley Sandvall; Ugochi C Okoroafor; William Gerull; Jason Guattery; Ryan P Calfee Journal: J Hand Surg Am Date: 2019-04-04 Impact factor: 2.230
Authors: Amelia A Sorensen; Daniel Howard; Wen Hui Tan; Jeffrey Ketchersid; Ryan P Calfee Journal: J Hand Surg Am Date: 2013-03-06 Impact factor: 2.230
Authors: Steven D Glassman; Anne G Copay; Sigurd H Berven; David W Polly; Brian R Subach; Leah Y Carreon Journal: J Bone Joint Surg Am Date: 2008-09 Impact factor: 5.284
Authors: Sara S McMillan; Elizabeth Kendall; Adem Sav; Michelle A King; Jennifer A Whitty; Fiona Kelly; Amanda J Wheeler Journal: Med Care Res Rev Date: 2013-07-26 Impact factor: 3.929
Authors: Aaron J Kaat; Chester Trip Buckenmaier; Karon F Cook; Nan E Rothrock; Benjamin D Schalet; Richard C Gershon; Mark S Vrahas Journal: J Patient Rep Outcomes Date: 2019-11-26